Southport Management’s Pfizer PFE Stock Holding History

Southport Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-15,000	Closed	-$380K	–	32
2025 Q1	$380K	Sell	15,000 -10,000	-40%	-$262K	1.64%	21
2024 Q4	$663K	Hold	25,000	–	–	2.4%	21
2024 Q3	$724K	Buy	+25,000	New	+$729K	2.69%	16
2014 Q1	–	Sell	-28,985	Closed	-$842K	–	40
2013 Q4	$842K	Hold	28,985	–	–	0.97%	29
2013 Q3	$790K	Sell	28,985 -89,590	-76%	-$2.44M	1.33%	19
2013 Q2	$3.15M	Buy	+118,575	New	+$3.28M	4.43%	6

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Southport Management's PFE Position: Q2 2025 in Review

Southport Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 15,000 shares — an estimated $380K sold.

Southport Management first reported a position in PFE in Q2 2013 and held it in 6 quarters. The position peaked at $3.15M in Q2 2013. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Southport Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Southport Management sold 15,000 Pfizer shares in Q2 2025, an estimated $380K.
Southport Management first reported a position in Pfizer in Q2 2013 and held it in 6 quarters.
Southport Management's Pfizer position peaked at $3.15M in Q2 2013.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Southport Management's 13F filing for Q2 2025, filed 14 Aug 2025.